
Looking forward to @AACR 2023 annual meeting. Exciting talks ahead!
English
Parth Desai
25 posts

@ParthDe93098240
Physician scientist in the making

























#OncoAlert BMS withdraws indication of 3L nivolumab for #SCLC. Durable responses in CM-032 led to FDA accelerated approval but the randomized confirmatory phase III studies were negative: CM331 (2nd line vs topo) and CM451 (maintenance vs placebo) #LCSM news.bms.com/news/corporate…
